Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of …

T Minier, S Guiducci, S Bellando-Randone… - Annals of the …, 2014 - ard.bmj.com
Objectives The EULAR (European League Against Rheumatism) Scleroderma Trials and
Research Group (EUSTAR) has identified preliminary criteria for very early diagnosis of …

[HTML][HTML] COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series

…, GP Mariano, A Spinella, S Bellando-Randone… - Clinical …, 2020 - Springer
Introduction Covid-19 infection poses a serious challenge for immune-compromised
patients with inflammatory autoimmune systemic diseases. We investigated the clinical-…

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis

…, I Rosa, S Guiducci, S Bellando-Randone… - Annals of the …, 2017 - ard.bmj.com
Objective Systemic sclerosis (SSc) features multiorgan fibrosis orchestrated predominantly
by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a …

Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic …

…, C Ceccarelli, S Bellando-Randone… - Circulation …, 2011 - Am Heart Assoc
Rationale: Systemic sclerosis (SSc) is characterized by widespread microangiopathy,
fibrosis, and autoimmunity. Despite the lack of angiogenesis, the expression of vascular …

“To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity

S Cappelli, SB Randone, D Martinović… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVES: To determine if mixed connective tissue disease (MCTD) can be considered
an independent clinical entity, to compare 3 different classification criteria for MCTD (…

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis

…, L Gargani, S Guiducci, SB Randone… - Annals of the …, 2013 - ard.bmj.com
Background A high percentage of patients with systemic sclerosis (SSc) develop interstitial
lung disease (ILD) during the course of the disease. Promising data have recently shown that …

[HTML][HTML] Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, R Gerli, E Bartoloni, S Bellando Randone… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Interstitial lung disease in systemic sclerosis: where do we stand?

S Cappelli, SB Randone, G Camiciottoli… - European …, 2015 - Eur Respiratory Soc
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite
recent advances in the treatment is, at present, the major cause of death. Today, an early …

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report

…, AF Milia, S Bellando-Randone… - Annals of internal …, 2010 - acpjournals.org
Background: Mesenchymal stem cells can differentiate into endothelial cells and participate
in angiogenesis in adults. In experimental models of acute myocardial infarction, …

Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre …

S Bellando-Randone, F Del Galdo, G Lepri… - The Lancet …, 2021 - thelancet.com
Background Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS)
have been previously proposed to identify signs and symptoms in patients with Raynaud's …